| Identification | Back Directory | [Name]
gomisin J | [CAS]
66280-25-9 | [Synonyms]
gomisin J
(6R,7S)-1,2,11,12-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulene-3,10-diol
(6R,7S,12aS)-5,6,7,8-Tetrahydro-1,2,11,12-tetramethoxy-6,7-dimethyldibenzo[a,c]cyclooctene-3,10-diol
Dibenzo[a,c]cyclooctene-3,10-diol, 5,6,7,8-tetrahydro-1,2,11,12-tetramethoxy-6,7-dimethyl-, (6R,7S,12aS)- | [EINECS(EC#)]
200-258-5 | [Molecular Formula]
C22H28O6 | [MDL Number]
MFCD29048562 | [MOL File]
66280-25-9.mol | [Molecular Weight]
388.45 |
| Chemical Properties | Back Directory | [Melting point ]
148-149℃ | [Boiling point ]
587.5±50.0 °C(Predicted) | [density ]
1.161 | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [pka]
8.97±0.60(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Gomisin J is a promising drug for anti-ovarian cancer utilization. Also, it exhibits strong inhibition towards the glucuronidation of SN-8. |
|
|